CONMED Corp — Director's Dealing 2015

Feb 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2015-02-02

Reporting Person: Darling Joseph G (EVP, Commercial Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-02	Common Stock	M	10000	$26.69	Acquired	22015	Direct
2015-02-02	Common Stock	F	6893	$47.85	Disposed	15122	Direct
2015-02-02	Common Stock	M	4000	$26.09	Acquired	19122	Direct
2015-02-02	Common Stock	F	2722	$47.85	Disposed	16400	Direct
2015-02-02	Common Stock	M	2000	$32.93	Acquired	18400	Direct
2015-02-02	Common Stock	F	1563	$47.85	Disposed	16837	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-02	Sars (Stock Appreciation Rights)	$26.69	M	10000	Disposed	2018-06-01	Common Stock (10000)	Direct
2015-02-02	Sars (Stock Appreciation Rights)	$26.09	M	4000	Disposed	2022-06-01	Common Stock (4000)	Direct
2015-02-02	Sars (Stock Appreciation Rights)	$32.93	M	2000	Disposed	2023-06-01	Common Stock (2000)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.

F2: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.